首页|UGT1A4-142T>G基因多态性与双相情感障碍患儿体内拉莫三嗪血药浓度的相关性

UGT1A4-142T>G基因多态性与双相情感障碍患儿体内拉莫三嗪血药浓度的相关性

扫码查看
目的 分析评估UGT1A4-142T>G基因多态性对双相情感障碍患儿拉莫三嗪血浆浓度的影响。方法 收集2019年1月至2024年5月就诊于新疆维吾尔自治区人民医院的因双相情感障碍服用拉莫三嗪治疗至少21 d患儿的血样,采用超高效液相色谱法测定拉莫三嗪血浆药物浓度,采用第一代Sanger测序方法检测患儿UGT1A4-142T>G基因型,分析患儿UGT1A4-142T>G基因多态性与拉莫三嗪血药浓度的相关性。结果 共收集82例患儿,男14例,女68例,平均年龄为(15。51±1。72)岁,拉莫三嗪平均给药剂量为(196。54±90。25)mg/d,平均血药浓度为(4。66±2。64)μg/mL,平均浓度剂量比(CDR)为(1。44±1。22)μg·kg/(mL·mg)。患儿拉莫三嗪血药浓度与给药剂量呈正相关(r=0。541,P<0。05)。UGT1A4-142T>G基因分型分别为TT基因型(52例)、GT基因型(25例)和GG基因型(5例)。UGT1A4-142T>G不同基因型患儿的性别、年龄、BMI、拉莫三嗪给药剂量、拉莫三嗪血药浓度和CDR比较,差异均有统计学意义(P<0。05)。其中,GG基因型组患儿的年龄大于TT基因型组[(16。34±1。19)岁比(15。77±1。54)岁],BMI低于TT基因型组[(18。69±2。34)kg/m2比(20。72±3。53)kg/m2],拉莫三嗪血药浓度高于TT基因型组[(5。63±1。48)μg/mL和(4。56±2。82)μg/mL],差异均有统计学意义(P<0。05);GT基因型组患儿的BMI、拉莫三嗪给药剂量低于TT基因型组[(19。87±5。01)kg/m2比(20。72±3。53)kg/m2,(164。79±77。95)mg/d和(208。26±86。95)mg/d],CDR高于TT基因型组[(1。78±1。24)μg·kg/(mL·mg)和(1。33±1。15)μg·kg/(mL·mg)],差异均有统计学意义(P<0。05)。结论 UGT1A4-142T>G基因突变影响拉莫三嗪血药浓度,双相情感障碍患儿如需使用拉莫三嗪建议检测UGT1A4-142T>G的遗传表型。
Correlation between UGT1A4-142T>G gene polymorphisms and plasma concentrations of lamotrigine in children with bipolar disorder
Objective To analyze the impact of UGT1A4-142T>G gene polymorphism on the plasma concentration of lamotrigine in children with bipolar disorder.Methods Blood samples were collected from patients with bipolar disorder who were treated with lamotrigine for at least 21 days between January 2019 and May 2024 at the People's Hospital of Xinjiang Uygur Autonomous Region.The plasma concentration of lamotrigine was determined using ultra-high-performance liquid chromatography.The UGT1A4-142T>G genotype of the children was detected using the first-generation Sanger sequencing method,and the correlation between the UGT1A4-142T>G gene polymorphism and the plasma concentration of lamotrigine was analyzed.Results A total of 82 children were enrolled,including 14 males and 68 females,with an average age of(15.51±1.72)years.The average dosage of lamotrigine was(196.54±90.25)mg/d and the average plasma concentration of lamotrigine was(4.66±2.64)μg/mL.The average concentration-to-dose ratio(CDR)was(1.44±1.22)μg·kg/(mL·mg).There was a positive correlation between the plasma concentration of lamotrigine and the dosage(r=0.541,P<0.05).The UGT1A4-142T>G genotypes were distributed as follows:TT genotype(52 cases),GT genotype(25 cases),and GG genotype(5 cases).Comparisons of gender,age,BMI,lamotrigine dosage,plasma concentration of lamotrigine,and CDR among children with different UGT1A4-142T>G genotypes showed statistically significant differences(P<0.05).Specifically,children with the GG genotype were older than those with the TT genotype[(16.34±1.19)years vs(15.77±1.54)years],had lower BMI than the TT genotype[(18.69±2.34)kg/m2 vs(20.72±3.53)kg/m2],and had higher plasma concentration of lamotrigine than the TT genotype[(5.63±1.48)μg/mL vs(4.56±2.82)μg/mL],with all differences being statistically significant(P<0.05).Children with the GT genotype had lower BMI and lamotrigine dosage than the TT genotype[(19.87±5.01)kg/m2 vs(20.72±3.53)kg/m2,(164.79±77.95)mg/d vs(208.26±86.95)mg/d],and higher CDR than the TT genotype[(1.78±1.24)μg·kg/(mL·mg)vs(1.33±1.15)μg·kg/(mL·mg)],with all differences being statistically significant(P<0.05).Conclusion The UGT1A4-142T>G gene mutation affects the plasma concentration of lamotrigine,and it is recommended to test the genetic phenotype of UGT1A4-142T>G before using lamotrigine in children with bipolar disorder.

UGT1A4bipolar disorderlamotrigineplasma concentration

张惠兰、赵婷、李红健、于鲁海

展开 >

新疆维吾尔自治区人民医院 药学部 新疆维吾尔自治区临床药学研究所,乌鲁木齐 830001

UGT1A4 双相情感障碍 拉莫三嗪 血药浓度

2024

临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
年,卷(期):2024.22(10)